Close Menu

NEW YORK (GenomeWeb News) – Saladax Biomedical said this week that it plans to open a CLIA lab at its headquarters in Bethlehem, Pa. The firm has applied for approval from both the State of Pennsylvania and the federal government and is targeting a launch next year.

Saladax offers MyCare tests for individualized dose management of three cancer drugs: 5-fluorouracil, paclitaxel, and docetaxel. It has another 10 MyCare tests in development, it said, and plans to offer the tests through the CLIA lab.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.